slides · global inventory
Chart
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 78,129
Current window 21,931-21,960
Pages 2,605
Rows per page 30
Component
21,931-21,960 of 78,129
28
Includes survival curves (Kaplan-Meier), median survival bar chart, and bioluminescence imaging of tumor growth.Immix Biopharma | Investor Presentation Deck | 46 slides · Immix Biopharma
Pitch deck Investor relations 2 hits
38
Includes two sets of charts: tumor volume over time and survival curves for MDA-MB-231 and HCT-116 models.Immix Biopharma | Investor Presentation Deck | 46 slides · Immix Biopharma
Pitch deck Investor relations 2 hits
39
Includes multiple scientific diagrams and clinical trial data summaries.Immix Biopharma | Investor Presentation Deck | 46 slides · Immix Biopharma
Pitch deck Investor relations 2 hits
31
Includes survival curves (Kaplan-Meier), tumor imaging, and tumor frequency metrics.Immix Biopharma | Investor Presentation Deck | 49 slides · Immix Biopharma
Pitch deck Investor relations Beat · Impact & Next StepsLoop · Pareto Focus2 hits
40
Includes technical diagrams of the drug construct, comparative histology, and survival curves.Immix Biopharma | Investor Presentation Deck | 49 slides · Immix Biopharma
Pitch deck Investor relations Beat · Solution & Approach2 hits
41
Includes two sets of charts: tumor volume line graphs and survival curves. References Abouzeid et al. (2013/2014).Immix Biopharma | Investor Presentation Deck | 49 slides · Immix Biopharma
Pitch deck Investor relations Beat · Solution & Approach2 hits
42
Includes detailed scientific diagrams and references to clinical studies.Immix Biopharma | Investor Presentation Deck | 49 slides · Immix Biopharma
Pitch deck Investor relations Beat · Solution & Approach2 hits
12
Includes detailed clinical trial citations in the footer.Immix Biopharma | Investor Presentation Deck | 52 slides · Immix Biopharma
Pitch deck Investor relations Beat · Solution2 hits
33
Includes survival curves (Kaplan-Meier), median survival bar chart, and bioluminescence imaging of tumor regression.Immix Biopharma | Investor Presentation Deck | 52 slides · Immix Biopharma
Pitch deck Investor relations 2 hits
43
Includes two sets of charts: tumor volume line graphs and survival curves. References specific study methodology in footnotes.Immix Biopharma | Investor Presentation Deck | 52 slides · Immix Biopharma
Pitch deck Investor relations 2 hits
44
The slide uses a two-part structure: clinical efficacy (top right) and mechanism of action (bottom right).Immix Biopharma | Investor Presentation Deck | 52 slides · Immix Biopharma
Pitch deck Investor relations 2 hits
04
The slide highlights a CAGR of 5.3% for book value and an average ROE of 13.4% over the period, with a specific callout for the 2020 Nasdaq listing.International General Insurance | Results Presentation Deck | 20 slides · International General Insurance
Conference presentation Investor relations Beat · WhyLoop · Benchmark Gap2 hits
10
The slide highlights diversification across multiple dimensions including geography and lines of business.International General Insurance | Results Presentation Deck | 20 slides · International General Insurance
Conference presentation Investor relations Beat · Financial Performance OverviewLoop · Cost Of Inaction2 hits
12
The chart uses a dual-axis approach: stacked bars for loss amounts ($Billions) and a line graph for the Combined Ratio (%).International General Insurance | Results Presentation Deck | 20 slides · International General Insurance
Conference presentation Investor relations Beat · Financial Performance OverviewLoop · Cost Of Inaction2 hits
11
The slide uses stacked bar charts to show revenue composition across four segments: Data/Patient Network, Women's health, Rare diseases/Other, and Oncology.Invitae | Results Presentation Deck | 28 slides · Invitae
Conference presentation Investor relations Beat · Key Performance Indicators OverviewLoop · Zoom In2 hits
08
The slide uses bar charts to compare ASMs and Revenue growth guidance for Q2 and Q3.jetBlue | Results Presentation Deck | 19 slides · jetBlue
Conference presentation Investor relations 2 hits
04
TPD = Targeted Protein Degradation. The slide uses a four-column layout to structure the company's value proposition.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations Beat · InterestLoop · Logic Chain2 hits
18
The slide compares cytokine inhibition across three cohorts (MAD3 Healthy Subjects, Part C AD Patients, Part C HS Patients) using two different stimuli (LPS and R848).Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations Beat · Desire2 hits
23
Includes before/after photography, clinical efficacy table, and biomarker reduction charts.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations Beat · DesireLoop · Aha Moment2 hits
27
The charts demonstrate a shift from higher severity scores (orange/red) to lower severity scores (blue/black) over time.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations Beat · Desire2 hits
36
The slide presents two charts: a tumor growth inhibition curve and a PK/PD correlation chart showing drug concentration vs. target degradation over time.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 2 hits
43
The slide presents two charts: a tumor volume growth curve over time and a PK/PD profile showing drug concentration and target knockdown over 240 hours.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations Loop · Golden Circle2 hits
54
Data presented as tumor volume growth curves and Kaplan-Meier survival plots.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 2 hits
56
Shows two distinct experiments: DFAM-68555 (leukemia burden) and MOLM-13 (tumor volume).Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 2 hits
03
Includes fiscal year end note.Lakeland Bancorp | Investor Conference Presentation Deck | 19 slides · Lakeland
Conference presentation Investor relations Beat · AttentionLoop · Why Now2 hits
06
The chart uses a dual-axis approach to show revenue (bars) and margins (line/shaded area).Lakeland Bancorp | Investor Conference Presentation Deck | 19 slides · Lakeland
Conference presentation Investor relations Beat · KPI OverviewLoop · Cost Of Inaction2 hits
07
The chart uses a combination of bar (Net Sales) and line (Margins) to visualize the impact of the pandemic on financial performance.Lakeland Bancorp | Investor Conference Presentation Deck | 19 slides · Lakeland
Conference presentation Investor relations Beat · KPI OverviewLoop · Cost Of Inaction2 hits
11
Lakeland Bancorp | Investor Conference Presentation Deck | 19 slidesLakeland Bancorp | Investor Conference Presentation Deck | 19 slides · Lakeland
Conference presentation Investor relations 2 hits
15
DOS refers to Directly Operated Stores including shop-in-shop, retail, outlet & pop-up stores.Lanvin | Results Presentation Deck | 36 slides · Lanvin Group
Conference presentation Investor relations Beat · SatisfactionLoop · Before After2 hits
17
Includes a bar chart for revenue, a combination bar/line chart for operating profit and margin, and three big-number callouts.Lenovo | Results Presentation Deck | 29 slides · Lenovo
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction2 hits